OrbiMed’s Flexion Therapeutics, Inc. FLXN Stock Holding History

OrbiMed’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,769,383	Closed	-$16.9M	–	184
2021 Q3	$16.9M	Hold	2,769,383	–	–	0.19%	106
2021 Q2	$22.8M	Buy	2,769,383 +461,300	+20%	+$3.92M	0.23%	91
2021 Q1	$20.7M	Hold	2,308,083	–	–	0.19%	99
2020 Q4	$26.6M	Buy	2,308,083 +624,083	+37%	+$7.25M	0.23%	87
2020 Q3	$17.5M	Hold	1,684,000	–	–	0.22%	90
2020 Q2	$22.1M	Buy	1,684,000 +1,551,000	+1,166%	+$16.1M	0.31%	71
2020 Q1	$1.05M	Hold	133,000	–	–	0.02%	134
2019 Q4	$2.75M	Buy	+133,000	New	+$2.24M	0.04%	116
2019 Q3	–	Sell	-89,919	Closed	-$1.11M	–	144
2019 Q2	$1.11M	Buy	+89,919	New	+$1.04M	0.02%	126

OrbiMed's FLXN Position: Q4 2021 in Review

OrbiMed sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 2,769,383 shares — an estimated $16.9M sold.

OrbiMed first reported a position in FLXN in Q2 2019 and held it in 9 quarters. The position peaked at $26.6M in Q4 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

OrbiMed reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
OrbiMed sold 2,769,383 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $16.9M.
OrbiMed first reported a position in Flexion Therapeutics, Inc. in Q2 2019 and held it in 9 quarters.
OrbiMed's Flexion Therapeutics, Inc. position peaked at $26.6M in Q4 2020.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on OrbiMed's 13F filing for Q4 2021, filed 14 Feb 2022.